ZPHC Cabergoline — 0.25 mg (50 tablets)
ALSO KNOWN AS
- Dostinex
- Cabaser
- Cabergoline
DESCRIPTION
ZPHC Cabergoline is a dopamine agonist commonly used in research for regulating prolactin levels. It works by stimulating Dâ‚‚ receptors in the pituitary gland, effectively lowering serum prolactin. This makes it a valuable tool in studies involving prolactin-related side effects from anabolic compounds like Trenbolone and Nandrolone, as well as models related to libido, erectile function, and mood regulation.
DOSAGE & ADMINISTRATION
- Form: Oral tablets
• Strength: 0.25 mg per tablet
• Typical Research Dosage:
– 0.25 mg twice weekly
– Max guideline dose: up to 1 mg/week based on bloodwork
• Administration: Swallowed whole with water
CYCLE USE
Used in research alongside 19-nor compounds (e.g. Trenbolone, Nandrolone) to control prolactin-related side effects such as gynecomastia, water retention, mood swings, and libido suppression. Also investigated in models of hyperprolactinemia, sexual dysfunction, and neuroendocrine studies.
PACKAGE CONTENTS
50 film-coated tablets × 0.25 mg each
STORAGE INSTRUCTIONS
- Store in a cool, dry place
- Keep away from direct sunlight
- Keep out of reach of children
